IL10 and colitis: IL-10−/− group receiving resveratrol showed a similar survival rate of 60%, but it is noteworthy that onset of colitis and end point scores for these animals were achieved clearly later (day 64) in the experimental time course compared to control IL-10−/− groups receiving no additive (day 50) or ethanol (day 51) (Figure 3F).